Assessing the Economic Value of Anticancer Therapies

  • Niels Neymark
Conference proceedings

Part of the Recent Results in Cancer Research book series (RECENTCANCER, volume 148)

Table of contents

  1. Front Matter
    Pages I-XI
  2. Niels Neymark
    Pages 1-8
  3. Niels Neymark
    Pages 9-14
  4. Niels Neymark
    Pages 42-53
  5. Niels Neymark
    Pages 54-78
  6. Niels Neymark
    Pages 79-96
  7. Niels Neymark
    Pages 97-113
  8. Niels Neymark
    Pages 114-132
  9. Niels Neymark
    Pages 133-155
  10. Niels Neymark
    Pages 156-182
  11. Niels Neymark
    Pages 183-210
  12. Niels Neymark
    Pages 211-247
  13. Niels Neymark
    Pages 248-262
  14. Niels Neymark
    Pages 263-275
  15. Back Matter
    Pages 277-285

About these proceedings


With ever increasing demands on the constrained resources available for health care services, no one involved in decision making in health care can continue to ignore the economic costs of the services provided or the relative value for money offered by the available treatments. Economic evaluation has therefore become an important and indispensable tool for medical deci­ sion making, alongside the well-known methods for clinical eval­ uation. This is also true for cancer, despite the aura of sanctity often of surrounding this dreaded disease and the apparent willingness the general population to spend large sums in this area and do "everything possible" for the patients. In recent years, articles dealing with assessing the costs and benefits of various cancer treatments have begun to appear in scientific medical and eco­ nomic journals. This book provides a comprehensive survey and assessment of the current state of the art of economic evaluations and cost ana­ lyses in cancer. It gives an introduction to the methods available for economic evaluations, before surveying and assessing the available publications. Separate chapters are devoted to the most prevalent cancers, and in each chapter the current clinical prac­ tice and research problems are summarized in order to provide a background for the economic analyses. At the end, a summary assessment of the literature is provided along with some sugges­ tions for a future research agenda.


Krebstherapien anti-cancer therapies breast cancer cancer cancer therapy colorectal cancer cost analyses epidemiology leukemia lung cancer lymphoma ovarian cancer pain prostate cancer transplantation

Authors and affiliations

  • Niels Neymark
    • 1
  1. 1.EORTC Health Economics UnitBrusselsBelgium

Bibliographic information

  • DOI
  • Copyright Information Springer-Verlag Berlin Heidelberg 1998
  • Publisher Name Springer, Berlin, Heidelberg
  • eBook Packages Springer Book Archive
  • Print ISBN 978-3-642-72125-0
  • Online ISBN 978-3-642-72123-6
  • Series Print ISSN 0080-0015
  • Buy this book on publisher's site
Industry Sectors
Health & Hospitals
Oncology & Hematology